ENTRY       hsa04664                    Pathway
NAME        Fc epsilon RI signaling pathway - Homo sapiens (human)
DESCRIPTION Fc epsilon RI-mediated signaling pathways in mast cells are initiated by the interaction of antigen (Ag) with IgE bound to the extracellular domain of the alpha chain of Fc epsilon RI. The activation pathways are regulated both positively and negatively by the interactions of numerous signaling molecules. Mast cells that are thus activated release preformed granules which contain biogenic amines (especially histamines) and proteoglycans (especially heparin). The activation of phospholipase A2 causes the release of membrane lipids followed by development of lipid mediators such as leukotrienes (LTC4, LTD4 and LTE4) and prostaglandins (especially PDG2). There is also secretion of cytokines, the most important of which are TNF-alpha, IL-4 and IL-5. These mediators and cytokines contribute to inflammatory responses.
CLASS       Organismal Systems; Immune system
PATHWAY_MAP hsa04664  Fc epsilon RI signaling pathway
DRUG        D03095  Benzylpenicilloyl polylysine (USP)
            D03117  Binetrakin (USAN/INN)
            D04358  Golimumab (USAN/INN)
            D05251  Omalizumab (USAN/INN)
            D05671  Quiflapon sodium (USAN)
            D06664  Veliflapon (USAN/INN)
            D10069  Fiboflapon (USAN)
            D10122  Fiboflapon sodium (USAN)
            D11070  Tirabrutinib hydrochloride (JAN/USAN)
            D11275  Rosiptor (USAN/INN)
            D11276  Rosiptor acetate (USAN)
            D11873  Rilzabrutinib (JAN/USAN/INN)
            D12158  Elsubrutinib (USAN/INN)
            D12160  Orelabrutinib (USAN/INN)
            D12285  Remibrutinib (JAN/USAN/INN)
            D12489  Atuzabrutinib (USAN/INN)
            D12594  Tirabrutinib (USAN/INN)
            D12953  Sovleplenib (USAN/INN)
            D12954  Sovleplenib acetate (USAN)
            D13054  Lunsekimig (USAN/INN)
DBLINKS     GO: 0045576
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
            100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]
            102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]
            10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]
            110117499  P3R3URF-PIK3R3; P3R3URF-PIK3R3 readthrough [KO:K02649]
            123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]
            1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            1437  CSF2; colony stimulating factor 2 [KO:K05427]
            207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
            2205  FCER1A; Fc epsilon receptor Ia [KO:K08089]
            2206  MS4A2; membrane spanning 4-domains A2 [KO:K08090]
            2207  FCER1G; Fc epsilon receptor Ig [KO:K07983]
            240  ALOX5; arachidonate 5-lipoxygenase [KO:K00461] [EC:1.13.11.34]
            241  ALOX5AP; arachidonate 5-lipoxygenase activating protein [KO:K20735]
            2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]
            255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]
            27040  LAT; linker for activation of T cells [KO:K07362]
            283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]
            2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]
            3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]
            3562  IL3; interleukin 3 [KO:K04736]
            3565  IL4; interleukin 4 [KO:K05430]
            3567  IL5; interleukin 5 [KO:K05428]
            3596  IL13; interleukin 13 [KO:K05435]
            3635  INPP5D; inositol polyphosphate-5-phosphatase D [KO:K03084] [EC:3.1.3.86]
            3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]
            3937  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]
            4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]
            4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]
            5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]
            5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
            5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
            5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]
            5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]
            5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]
            5879  RAC1; Rac family small GTPase 1 [KO:K04392]
            5880  RAC2; Rac family small GTPase 2 [KO:K07860]
            5881  RAC3; Rac family small GTPase 3 [KO:K07861]
            5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
            6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
            6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
            6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
            6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]
            695  BTK; Bruton tyrosine kinase [KO:K07370] [EC:2.7.10.2]
            7124  TNF; tumor necrosis factor [KO:K03156]
            7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]
            7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]
            8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]
            9846  GAB2; GRB2 associated binding protein 2 [KO:K08091]
COMPOUND    C00076  Calcium cation
            C00165  Diacylglycerol
            C00219  Arachidonate
            C00374  Heparin
            C00388  Histamine
            C00696  Prostaglandin D2
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C02166  Leukotriene C4
            C05951  Leukotriene D4
            C05952  Leukotriene E4
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:12360215
  AUTHORS   Kawakami T, Galli SJ.
  TITLE     Regulation of mast-cell and basophil function and survival by IgE.
  JOURNAL   Nat Rev Immunol 2:773-86 (2002)
            DOI:10.1038/nri914
REFERENCE   PMID:14630197
  AUTHORS   Siraganian RP.
  TITLE     Mast cell signal transduction from the high-affinity IgE receptor.
  JOURNAL   Curr Opin Immunol 15:639-46 (2003)
            DOI:10.1016/j.coi.2003.09.010
REFERENCE   
  AUTHORS   Janeway CA, Travers P, Walport M, Shlomchik MJ.
  TITLE     Immunobiology 6th edition
  JOURNAL   Garland Science Publishing (2005)
REFERENCE   PMID:10586892
  AUTHORS   Turner H, Kinet JP.
  TITLE     Signalling through the high-affinity IgE receptor Fc epsilonRI.
  JOURNAL   Nature 402:B24-30 (1999)
            DOI:10.1038/35037021
REFERENCE   PMID:16470226
  AUTHORS   Gilfillan AM, Tkaczyk C.
  TITLE     Integrated signalling pathways for mast-cell activation.
  JOURNAL   Nat Rev Immunol 6:218-30 (2006)
            DOI:10.1038/nri1782
REFERENCE   PMID:11079101
  AUTHORS   Nadler MJ, Matthews SA, Turner H, Kinet JP.
  TITLE     Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function.
  JOURNAL   Adv Immunol 76:325-55 (2000)
            DOI:10.1016/S0065-2776(01)76022-1
REFERENCE   PMID:11449275
  AUTHORS   Gu H, Saito K, Klaman LD, Shen J, Fleming T, Wang Y, Pratt JC, Lin G, Lim B, Kinet JP, Neel BG.
  TITLE     Essential role for Gab2 in the allergic response.
  JOURNAL   Nature 412:186-90 (2001)
            DOI:10.1038/35084076
REFERENCE   PMID:12145654
  AUTHORS   Nadler MJ, Kinet JP.
  TITLE     Uncovering new complexities in mast cell signaling.
  JOURNAL   Nat Immunol 3:707-8 (2002)
            DOI:10.1038/ni0802-707
REL_PATHWAY hsa00590  Arachidonic acid metabolism
            hsa04010  MAPK signaling pathway
            hsa04070  Phosphatidylinositol signaling system
KO_PATHWAY  ko04664
///
